Brentuximab vedotin in patients with Hodgkin lymphoma and a failed allogeneic stem cell transplantation: results from a named patient program at four Italian centers.
Carlo-Stella C
Oncologist. 2015 Feb 10;20(3):323-8. doi: 10.1634/theoncologist.2014-0420
Infections after T-replete haploidentical transplantation and high-dose cyclophosphamide as graft-versus-host disease prophylaxis.
Crocchiolo R
Transpl Infect Dis. 17(2):242-9. doi: 10.1111/tid.12365
High-dose melphalan with autologous stem cell support in refractory Hodgkin lymphoma patients as a bridge to second transplant.
Castagna L
Bone Marrow Transplant. 2015 Jan 26;50(4):499-504. doi: 10.1038/bmt.2014.304
Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells.
Reichel J
Blood. 2014 Dec 8;125(7):1061-72. doi: 10.1182/blood-2014-11-610436
High-dose sequential chemotherapy (HDS) versus PEB chemotherapy as first-line treatment of patients with poor prognosis germ-cell tumors: mature results of an Italian randomized phase II study.
Necchi A
Ann Oncol. 2014 Oct 24;26(1):167-172. doi: 10.1093/annonc/mdu485
YM155 sensitizes triple-negative breast cancer to membrane-bound TRAIL through p38 MAPK- and CHOP-mediated DR5 upregulation.
Pennati M
Int J Cancer. 2014 Jun 5;136(2):299-309. doi: 10.1002/ijc.28993
Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomas.
Castagna L
Bone Marrow Transplant. 2014 Sep 15;49(12):1475-80. doi: 10.1038/bmt.2014.197
Synergistic anti-tumor activity and inhibition of angiogenesis by cotargeting of oncogenic and death receptor pathways in human melanoma.
Grazia G
Cell Death Dis. 2014 Oct 2;5(10):e1434. doi: 10.1038/cddis.2014.410
Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases.
Guidetti A
Clin Cancer Res. 2014 Sep 19;20(22):5641-51. doi: 10.1158/1078-0432.CCR-14-0770
Role of alpha-synuclein in autophagy modulation of primary human T lymphocytes.
Colasanti T
Cell Death Dis. 2014 May 29;5(5):e1265. doi: 10.1038/cddis.2014.211